These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 35344152)
1. Circulating Level of Blood Iron and Copper Associated with Inflammation and Disease Activity of Rheumatoid Arthritis. Wang H; Zhang R; Shen J; Jin Y; Chang C; Hong M; Guo S; He D Biol Trace Elem Res; 2023 Jan; 201(1):90-97. PubMed ID: 35344152 [TBL] [Abstract][Full Text] [Related]
2. Thresholds for the 28-joint disease activity score (DAS28) using C-reactive protein are lower compared to DAS28 using erythrocyte sedimentation rate in early rheumatoid arthritis. Kuriya B; Schieir O; Lin D; Xiong J; Pope J; Boire G; Haraoui B; Thorne JC; Tin D; Hitchon C; Jamal S; Keystone E; Bykerk VP; Clin Exp Rheumatol; 2017; 35(5):799-803. PubMed ID: 28339365 [TBL] [Abstract][Full Text] [Related]
3. The diagnostic utility of anti-cyclic citrullinated peptide antibodies, matrix metalloproteinase-3, rheumatoid factor, erythrocyte sedimentation rate, and C-reactive protein in patients with erosive and non-erosive rheumatoid arthritis. Shovman O; Gilburd B; Zandman-Goddard G; Sherer Y; Orbach H; Gerli R; Shoenfeld Y Clin Dev Immunol; 2005 Sep; 12(3):197-202. PubMed ID: 16295525 [TBL] [Abstract][Full Text] [Related]
4. Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan. Matsui T; Kuga Y; Kaneko A; Nishino J; Eto Y; Chiba N; Yasuda M; Saisho K; Shimada K; Tohma S Ann Rheum Dis; 2007 Sep; 66(9):1221-6. PubMed ID: 17369281 [TBL] [Abstract][Full Text] [Related]
5. Anti-CCP-positive patients with RA have a higher 10-year probability of fracture evaluated by FRAX®: a registry study of RA with osteoporosis/fracture. Cheng TT; Yu SF; Su FM; Chen YC; Su BY; Chiu WC; Hsu CY; Chen JF; Ko CH; Lai HM Arthritis Res Ther; 2018 Jan; 20(1):16. PubMed ID: 29382355 [TBL] [Abstract][Full Text] [Related]
7. Semi-quantitative analysis of Ravikanth R; Singh JK World J Nucl Med; 2020; 19(4):347-352. PubMed ID: 33623503 [No Abstract] [Full Text] [Related]
8. Infliximab equivalently suppresses oxidative stress compared to tocilizumab among well-controlled patients with rheumatoid arthritis. Kizaki K; Yamashita F; Hayashi T; Funakoshi N Int J Rheum Dis; 2018 Oct; 21(10):1815-1821. PubMed ID: 27778459 [TBL] [Abstract][Full Text] [Related]
9. Association between Rheumatoid Arthritis Disease Activity and Risk of Ovarian Malignancy in Middle-Aged and Elderly Women. Huang Z; Tan L; Ling Y; Huang F; Ma W Biomed Res Int; 2022; 2022():1062703. PubMed ID: 35663045 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the DAS28-CRP and DAS28-ESR in patients with rheumatoid arthritis. Sengul I; Akcay-Yalbuzdag S; Ince B; Goksel-Karatepe A; Kaya T Int J Rheum Dis; 2015 Jul; 18(6):640-5. PubMed ID: 26013310 [TBL] [Abstract][Full Text] [Related]
11. Association between butyrylcholinesterase activity and phenotypes, paraoxonase192 rs662 gene polymorphism and their enzymatic activity with severity of rheumatoid arthritis: correlation with systemic inflammatory markers and oxidative stress, preliminary report. Shahmohamadnejad S; Vaisi-Raygani A; Shakiba Y; Kiani A; Rahimi Z; Bahrehmand F; Shakiba E; Pourmotabbed T Clin Biochem; 2015 Jan; 48(1-2):63-9. PubMed ID: 25179377 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the disease activity score using the erythrocyte sedimentation rate and C-reactive protein levels in Koreans with rheumatoid arthritis. Son KM; Kim SY; Lee SH; Yang CM; Seo YI; Kim HA Int J Rheum Dis; 2016 Dec; 19(12):1278-1283. PubMed ID: 26200604 [TBL] [Abstract][Full Text] [Related]
13. Plasma metabolomic profiling in patients with rheumatoid arthritis identifies biochemical features predictive of quantitative disease activity. Hur B; Gupta VK; Huang H; Wright KA; Warrington KJ; Taneja V; Davis JM; Sung J Arthritis Res Ther; 2021 Jun; 23(1):164. PubMed ID: 34103083 [TBL] [Abstract][Full Text] [Related]
14. The relationships of CD8+ T cell subsets in RA patients with disease activity and clinical parameters. He J; Li Y; Chen J; Wu Q; Shan H; Wang X; Zhang M; Nie L; Wang Q Int Immunopharmacol; 2023 Jan; 114():109399. PubMed ID: 36442285 [TBL] [Abstract][Full Text] [Related]
15. Anticollagen type II antibodies are associated with an acute onset rheumatoid arthritis phenotype and prognosticate lower degree of inflammation during 5 years follow-up. Manivel VA; Mullazehi M; Padyukov L; Westerlind H; Klareskog L; Alfredsson L; Saevarsdottir S; Rönnelid J Ann Rheum Dis; 2017 Sep; 76(9):1529-1536. PubMed ID: 28336519 [TBL] [Abstract][Full Text] [Related]
16. Impact of disease activity on impaired glucose metabolism in patients with rheumatoid arthritis. Ristić GG; Subota V; Stanisavljević D; Vojvodić D; Ristić AD; Glišić B; Petronijević M; Stefanović DZ Arthritis Res Ther; 2021 Mar; 23(1):95. PubMed ID: 33771189 [TBL] [Abstract][Full Text] [Related]
17. Increased Circulating Pentraxin 3 Levels in Patients with Rheumatoid Arthritis: A Meta-analysis. Guan SY; Chen Y; Shao M; Yang H; Xu W; Shuai Z; Zhao H; Zhao D; Pan F Curr Pharm Des; 2022; 28(27):2260-2269. PubMed ID: 35708089 [TBL] [Abstract][Full Text] [Related]
18. Circulating DNA methylation level of CXCR5 correlates with inflammation in patients with rheumatoid arthritis. Shi Y; Chang C; Xu L; Jiang P; Wei K; Zhao J; Xu L; Jin Y; Zhang R; Wang H; Qian Y; Qin Y; Ding Q; Jiang T; Guo S; Wang R; He D Immun Inflamm Dis; 2023 Jun; 11(6):e902. PubMed ID: 37382265 [TBL] [Abstract][Full Text] [Related]
19. Circulating microparticles remain associated with complement activation despite intensive anti-inflammatory therapy in early rheumatoid arthritis. van Eijk IC; Tushuizen ME; Sturk A; Dijkmans BA; Boers M; Voskuyl AE; Diamant M; Wolbink GJ; Nieuwland R; Nurmohamed MT Ann Rheum Dis; 2010 Jul; 69(7):1378-82. PubMed ID: 19919943 [TBL] [Abstract][Full Text] [Related]
20. High CD14+ peripheral monocytes expression of ALX/FPR2 and BLT1 in low disease activity and remission status in rheumatoid arthritis: a piltot study. Perniola S; Bizzoca R; Fornaro M; Alivernini S; Gremese E; Iannone F Clin Exp Rheumatol; 2022 May; 40(5):1019-1024. PubMed ID: 34494955 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]